Evaluation of Meibomian Gland Dysfunction Among Ophthalmic Healthcare Workers

References

• Korb DR, Henriquez AS. Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc. 1980;51(3):243–251.
   Google Scholar
• Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930–1937. doi:10.1167/iovs.10-6997b
   PubMed Web of Science ®Google Scholar
• Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea. 2006;25(10):1162–1167. doi:10.1097/01.ico.0000244875.92879.1a
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994–2005. doi:10.1167/iovs.10-6997e
   PubMed Web of Science ®Google Scholar
• Siak JJ, Tong L, Wong WL, et al. Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study. Cornea. 2012;31:1223–1228. doi:10.1097/ICO.0b013e31823f0977
   PubMed Web of Science ®Google Scholar
• Amano S, Inoue K. Clinic-based study on meibomian gland dysfunction in Japan. Invest Ophthalmol Vis Sci. 2017;58:1283–1287. doi:10.1167/iovs.16-21374
   PubMed Web of Science ®Google Scholar
• Cochener B, Cassan A, Omiel L. Prevalence of meibomian gland dysfunction at the time of cataract surgery. J Cataract Refract Surg. 2018;44(2):144–148. doi:10.1016/j.jcrs.2017.10.050
   PubMed Web of Science ®Google Scholar
• Zang S, Cui Y, Cui Y, Fei W. Meibomian gland dropout in Sjögren’s syndrome and non-Sjögren’s dry eye patients. Eye (Lond). 2018;32(11):1681–1687. doi:10.1038/s41433-018-0149-5
   Web of Science ®Google Scholar
• Finis D, Pischel N, Schrader S, Geerling G. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction. Cornea. 2013;32(12):1549–1553. doi:10.1097/ICO.0b013e3182a7f3e1
   PubMed Web of Science ®Google Scholar
• Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006–2049. doi:10.1167/iovs.10-6997f
   PubMed Web of Science ®Google Scholar
• Blackie CA, Solomon JD, Scaffidi RC, et al. The relationship between dry eye symptoms and lipid layer thickness. Cornea. 2009;28(7):789–794. doi:10.1097/ICO.0b013e318191b870
   PubMed Web of Science ®Google Scholar
• Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115(5):911–915. doi:10.1016/j.ophtha.2007.06.031
   PubMed Web of Science ®Google Scholar
• Den S, Shimizu K, Ikeda T, Tsubota K, Shimmura S, Shimazaki J. Association between meibomian gland changes and aging, sex, or tear function. Cornea. 2006;25(6):651–655. doi:10.1097/01.ico.0000227889.11500.6f
   PubMed Web of Science ®Google Scholar
• Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea. 1992;11(4):334–342. doi:10.1097/00003226-199207000-00012
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Agrawal D, Sharma A. Meibomian gland dysfunction in a hospital-based population in central India. Cornea. 2020;39(5):634–639. doi:10.1097/ICO.0000000000002217
   PubMed Web of Science ®Google Scholar
• Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8):762–770. doi:10.1097/01.ico.0000133997.07144.9e
   PubMed Web of Science ®Google Scholar
• Thulasi P, Djalilian AR. Update in current diagnostics and therapeutics of dry eye disease. Ophthalmology. 2017;124(11S):S27–S33. doi:10.1016/j.ophtha.2017.07.022
   PubMed Web of Science ®Google Scholar
• Nichols KK, Foulks GN, Bron AJ, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52(4):1922–1929. doi:10.1167/iovs.10-6997a
   PubMed Web of Science ®Google Scholar
• Borchman D, Foulks GN, Yappert MC, et al. Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52(6):3805–3817. doi:10.1167/iovs.10-6514
   PubMed Web of Science ®Google Scholar
• Kenrick CJ, Alloo SS. The limitation of applying heat to the external lid surface: a case of recalcitrant meibomian gland dysfunction. Case Rep Ophthalmol. 2017;8(1):7–12. doi:10.1159/000455087
   PubMed Web of Science ®Google Scholar
• Lane SS, DuBiner HB, Epstein RJ, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012;31(4):396–404. doi:10.1097/ICO.0b013e318239aaea
   PubMed Web of Science ®Google Scholar
• Hura AS, Epitropoulos AT, Czyz CN, Rosenberg ED. Visible meibomian gland structure increases after vectored thermal pulsation treatment in dry eye disease patients with meibomian gland dysfunction. Clin Ophthalmol. 2020;14:4287–4296. doi:10.2147/OPTH.S282081
   PubMed Web of Science ®Google Scholar
• Goldberg DJ. Current trends in intense pulsed light. J Clin Aesthet Dermatol. 2012;5(6):45–53.
   PubMedGoogle Scholar
• Sabeti S, Kheirkhah A, Yin J, Dana R. Management of meibomian gland dysfunction: a review. Surv Ophthalmol. 2020;65(2):205–217. doi:10.1016/j.survophthal.2019.08.007
   PubMed Web of Science ®Google Scholar
• Ma X, Lu Y. Efficacy of intraductal meibomian gland probing on tear function in patients with obstructive meibomian gland dysfunction. Cornea. 2016;35(6):725–730. doi:10.1097/ICO.0000000000000777
   PubMed Web of Science ®Google Scholar
• Butovich IA, Millar TJ, Ham BM. Understanding and analyzing meibomian lipids–a review. Curr Eye Res. 2008;33(5):405–420. doi:10.1080/02713680802018419
   PubMed Web of Science ®Google Scholar
• Sridharan K, Sivaramakrishnan G. Therapies for meibomian gland dysfunction: a systematic review and meta-analysis of randomized controlled trials. Open Ophthalmol J. 2017;11:346–354. doi:10.2174/1874364101711010346
   Web of Science ®Google Scholar
• Zhao Y, Veerappan A, Yeo S, et al. Clinical trial of thermal pulsation (LipiFlow) in meibomian gland dysfunction with preteatment meibography. Eye Contact Lens. 2016;42(6):339–346. doi:10.1097/ICL.0000000000000228
   PubMed Web of Science ®Google Scholar
• Finis D, Hayajneh J, Konig C, et al. Evaluation of an automated thermodynamic treatment (LipiFlow(R)) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf. 2014;12(2):146–154. doi:10.1016/j.jtos.2013.12.001
   PubMed Web of Science ®Google Scholar
• Finis D, Konig C, Hayajneh J, et al. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea. 2014;33(12):1265–1270. doi:10.1097/ICO.0000000000000273
   PubMed Web of Science ®Google Scholar
• Greiner JV. A single LipiFlow(R) Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012;37(4):272–278. doi:10.3109/02713683.2011.631721
   PubMed Web of Science ®Google Scholar
• Greiner JV. Long-term (3 year) effects of a single thermal pulsation system treatment on meibomian gland function and dry eye symptoms. Eye Contact Lens. 2016;42(2):99–107. doi:10.1097/ICL.0000000000000166
   PubMed Web of Science ®Google Scholar